FBIO
Fortress Biotech, Inc.
stockNASDAQ
fortress biotech, inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. fortress plans to develop and commercialize products that it acquires both directly as well as indirectly by establishing subsidiary companies, also known as fortress companies. the company will leverage its biopharmaceutical business expertise and drug development capabilities to help the fortress companies achieve their goals. additionally, the company will provide funding and management services to each of the fortress companies and from time to time the company and the fortress companies will seek licensing, partnerships, joint ventures, and/or public and private financings to accelerate and provide additional funding to support their research and development programs.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.90 | 2026-10-14 | +2.63% | 2.354 |
| 1M | 2.41 | 2026-09-21 | -19.09% | 2.073 |
| 3M | 3.53 | 2026-07-21 | -44.76% | 0.143 |
| 6M | 2.23 | 2026-04-21 | -12.56% | 1.006 |
| 1Y | 2.77 | 2025-10-21 | -29.60% | 1.204 |
| 2Y | 1.78 | 2024-10-21 | +9.55% | — |
| 5Y | 456.00 | 2021-10-21 | -99.57% | 1.224 |
Fortress Biotech, Inc. (NASDAQ:FBIO) stock price today is $1.95, and today's volume is 156,273. FBIO is up 0.515% today. The 30 day average volume is 272,348. FBIO market cap is $65.03M with 33.35M shares outstanding.